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Abstract Cyclophilin A (CyPA), a cytosolic peptidyl-prolyl 
trans-cis isomerase can accelerate the trans-cis isomerization of 
Xxx-Pro peptide bonds. One- and two-dimensional 1H-NMR 
spectroscopy were used to determine that the heptapeptide Ser-
Gln-Asn-Tyr-Pro-Ue-Val, a model peptide of an HIV-1 protease 
cleavage site in the gag polyprotein of HIV-1, is a substrate for 
CyPA. Experiments revealed a slow exchange about the Tyr-Pro 
peptide bond with 30 ± 5% in the cis conformation (pH 1-9). 
While the interconversion rate is too slow to measure by kinetic 
NMR methods in the absence of CyPA, these methods, 
saturation transfer and NOE experiments, established that 
CyPA enhanced the rate of trans-cis interconversion, a process 
inhibited by cyclosporin A (CsA). With a substrate:CyPA 
ratio of 40:1, an interconversion rate of 2.5 s _ 1 at 25°C was 
observed. 
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1. Introduction 
The mature virion of the human immunodeficiency virus 
type-1 (HIV-1) consists of viral proteins, the single stranded 
RNA genome, and enzymes required for replication. Subse-
quent to translation and incorporation into the immature vir-
ion, the precursor polyproteins are cleaved by HIV protease 
(Fig. 1). Cleavage of the gag, gag-pol, and env polyproteins 
produces the structural proteins: pi7 (MA), matrix protein; 
p24 (CA), capsid protein; p7 (NC), nucleocapsid protein; and 
p6; the enzymes: HIV protease (PR); reverse transcriptase 
(RT); and integrase (IN); and the envelope proteins: gpl20 
(SU) and gp41 (TM), respectively [1-3]. Inhibition of cleavage 
results in the production of poorly infectious virions [3,4]. One 
site of proteolytic cleavage has been shown to occur at the 
Tyr132/Pro133 peptide bond in the gag polyprotein (Fig. 1, Site 
1). It has been shown that the heptapeptide corresponding to 
residues 129-135 of the gag polyprotein functions as a suitable 
active model substrate [3]. 
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In addition to the enzymes encoded by the HIV-1 genome, 
CyPA is incorporated into the virion during assembly [5-8]. A 
member of the immunophilin family of enzymes possessing 
peptidyl-prolyl trans-cis isomerase activity [9], CyPA is the 
intracellular, cytosolic receptor for the immunosuppressive 
drug cyclosporin A, CsA [10]. The CyPA:CsA complex binds 
and inhibits calcineurin thereby inhibiting the gene transcrip-
tion of several cytokines in T-cells [11-13]. The family of 
immunophilins also functions as chaperone proteins as they 
catalyze trans-cis interconversion about Xxx-Pro peptide 
bonds, often a rate-determining step in protein folding 
[14,15]. In addition, it has been proposed that CyPA may 
function as a mediator of protein-protein interactions 
[13,16,17]. 
Previous studies have shown that CyPA binds to the capsid 
domain of the gag polyprotein (and subsequently to the cap-
sid protein) through a proline-rich region in the capsid do-
main, Pro(Xxx)4 Pro222(Xxx)2 Pro(Xxx)5Pro (Fig. IB) 
[7,8,10,18,19]. CyPA packaging into the virion is essential 
for viral infectivity as mutations in gag or reagents such as 
CsA which disrupt the gag-CyPA interaction inhibit viral rep-
lication [8,20-25]. Possible roles of CyPA in the life cycle of 
HIV-1 have been suggested based on the structural studies of 
Gitti et al. [26] and Gamble et al. [16]. Gitti and coworkers 
determined the solution structure of the amino-terminal two-
thirds of the capsid protein by NMR. Based on this structure, 
it was suggested that CyPA catalyzes the trans-cis intercon-
version about Pro90 of the capsid protein (Pro222 of intact 
gag polyprotein), a possible molecular switch in virion disas-
sembly. Gamble and coworkers determined the X-ray struc-
ture of a complex between the truncated capsid protein and 
CyPA. CyPA was found to interact with Pro90 and it was 
suggested that CyPA may function to weaken the association 
of the capsid protomers so as to function in virion disassem-
bly. The premise behind the current study is that CyPA, in 
addition to other possible functions, may catalyze isomeriza-
tion about the Xxx-Pro peptide bonds [9] in the gag polypro-
tein to the conformer cleaved by HIV protease. Noteworthy is 
the fact that of the eight cleavage sites in the gag and gag-pol 
polyproteins, three sites involve an Xxx-Pro scissile peptide 
bond (Fig. 1A) [4,27,28]. 
In this study, a potential mechanistic role for CyPA in the 
HIV-1 replicative cycle was probed using nuclear magnetic 
resonance (NMR) methods and the model Pro containing 
heptapeptide of the HIV-1 gag polyprotein. Saturation trans-
fer and nuclear Overhauser effect spectroscopy (NOESY) 
techniques were utilized to quantitate the peptidyl-prolyl 
trans-cis isomerization kinetics of the heptapeptide in the pres-
ence of CyPA. 
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2. Materials and methods 
2.1. Sample preparation 
The heptapeptide model substrate (Ser-Gln-Asn-Tyr-Pro-Ile-Val) 
was obtained from Sigma Chemical Company and used without fur-
ther purification. Samples were prepared by dissolving the heptapep-
tide in H 2 0 ,
2 H 2 0 , or a potassium phosphate (KPi)/
2H20 buffer (0.05 
M KPi, 0.15 M NaCl, and 0.02% NaN3). When needed, CyPA from a 
stock of recombinant CyPA (1 mg/ml) originating from a human 
Jurkat T-cell lymphoma line [29] and CsA (kindly supplied by J. Borel 
of Sandoz, Inc. of Switzerland) were added. Na0 2 H and 2HC1 were 
used to alter the pH of the sample as needed. 
2.2. NMR techniques 
JH-NMR spectra were recorded on a Bruker AMX500 NMR spec-
trometer. The data was processed with the Felix software (Biosym 
Technologies, San Diego, CA) running on a SGI computer. 
The trans-cis ratios at pH 9.15, 7.0, 5.73, and 1.56 in 2 H 2 0 were 
determined from 1-dimensional spectra at 25°C using 0.6 ml of a 
2 mM heptapeptide sample in a 5-mm NMR tube. The measurements 
were made using the following parameters: data points, 8K; scans, 
64; pulsewidth, 77°. The same method was used to determine the 
trans-cis ratio of the heptapeptide in a KPi/2H20 buffer. 
One-dimensional NOE difference experiments on the heptapeptide 
(1.6 mM) in the absence and presence of CyPA (25 iiM) with and 
without CsA (25 uM) were conducted in a KPi/2H20 buffer at pH 6.8. 
The measurements were made using 0.67 ml of each sample in a 5-mm 
NMR tube at 25°C. Three hundred and twenty transients were col-
lected in multiples of eight alternating between on and off-resonance 
saturation of the proline 8H resonance in the cis conformation at 3.37 
ppm. The parameters were as follows: 16K data points; on-resonance 
pulse, 3.32 ppm; and off-resonance pulse, 10.08 ppm. Exponential 
multiplication of the time domain signal by 5.0 Hz was used before 
Fourier transformation. To reduce the possibility of perturbation of 
the nearby downfleld cis multiplet, the selective saturation pulse was 
intentionally placed a few hundredths of a ppm to higher field from 
the center of the cis multiplet. 
Saturation transfer methods were used to measure exchange rates as 
previously reported [30] on the substrate (2.0 mM) in the absence and 
presence of CyPA (45 uM). The relationship between isomerization 
rate and saturation transfer is given by equation 1 [30,31]: 
( / , - /») / /o = e x p ( - J w ) (1) 
where lt is the intensity of the trans multiplet at 3.74 ppm after 
irradiation of its corresponding cis multiplet at 3.37 ppm for a time 
equals t; Ix is the intensity of the trans multiplet at 3.74 ppm after 
irradiation at 3.37 ppm for an infinite time; and Ia is the equilibrium 
intensity of the trans multiplet without irradiation of its corresponding 
cis multiplet at 3.37 ppm. The rate constant, fct-.c. f °
r trans-cis inter-
conversion, is given by the slope of the best fit line through the data 
on a plot of ln[(/t—Ix)/Io] vs. time /. The following NMR acquisition 
parameters were used: 128 scans, 8K data points, 77° pulse, and 25°C. 
The on-resonance pulse was applied at 3.32 ppm, the off-resonance at 
5.60 ppm, and the sweep width was 12 ppm. The saturation period of 
the cis multiplet was varied from 20 ms to 2.0 s. For the substrate in 
the presence of CyPA, this straight forward procedure was sufficient 
to determine the catalyzed trans-cis interconversion rate, kt^c, of the 
substrate at 25°C. On the other hand, the interconversion rate of the 
free substrate at 25°C was too slow to be measured by this technique 
which requires that the rates be within one order of magnitude of the 
T\. Higher temperatures (60—80°C) were attempted with the hope 
that an Arrhenius plot of the rates vs. temperature could be used to 
extrapolate back to the uncatalyzed tran-cis interconversion rate at 
25°C. 
Two-dimensional NOESY experiments were performed on sub-
strate (1.6 mM), substrate (1.6 mM):CyPA(25 uM), and substrate(1.6 
mM):CyPA(25 uM):CsA(25 I^M) samples in KPi/2H20 at pH 6.8. 
These measurements were made on 0.67 ml of sample in a 5-mm 
NMR tube with the following parameters: temperature 25°C, 512 
increments in t\, 2K complex data points in t2, 48 scans, 600 ms 
mixing time, and time-proportional phase incrementation, TPPI. 
3. Results and discussion 
Sequence-specific resonance assignments obtained from 
DQF-COSY spectra revealed separate resonances for the cis 
and trans conformers of the Tyr-Pro peptide bond in the 
heptapeptide substrate (Ser-Gln-Asn-Tyr-Pro-Ile-Val). The ar-
omatic region of the heptapeptide (Fig. 2A) exhibits splitting 
of both the 2,6 (5irans = 7.09 ppm) and the 3,5 (8frms = 6.76 ppm) 
proton resonances of Tyr. This splitting indicates a slow con-
formational exchange about the Tyr-Pro peptide bond. Fur-
ther support for the slow trans-cis interconversion is evidenced 
in a parallel splitting of the 5H prolyl resonances (Fig. 2B). 
Integration of either the aromatic resonances or the 8H prolyl 
resonances establishes a trans-cis ratio of 70:30 ±5% for the 
heptapeptide in either 2 H 2 0 or KPi/
2Ff20 which is pH-insen-
sitive throughout the pH range of 1 to 9. 
Fig. 3 shows the expansion of the aromatic region of the 
spectrum of the peptide alone and also with and without 
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Fig. 1. HIV-1 protease cleavage sites in the gag and gag-pol precursor polyproteins of HIV-1. (A) The amino acid sequences of the eight docu-
mented cleavage sites in the gag and gag-pol polyproteins. The asterisks indicate the scissile bonds. (B) A schematic depiction of the cleavage 
sites on the gag and gag-pol polyproteins. Numbered arrows indicate sites of cleavage and the mature proteins formed upon cleavage are indi-
cated as labeled fragments above and below the polyproteins. The CyPA binding site and its proline-rich sequence is indicated by an arrow to 
the precursor polyproteins and the capsid protein. 
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Fig. 2. Tyrosyl aromatic (A) and proline 8H (B) resonances of the heptapeptide substrate in 2H20 (Ser-Gln-Asn-Tyr-Pro-Ile-Val, 2 mM pep-
tide, and pH 7.0). 
CyPA and CsA. Comparison of the spectra of the free peptide 
(Fig. 3A) with the peptide in the presence of CyPA (Fig. 3B) 
indicates that CyPA enhances the rate of trans-cis isomeriza-
tion as seen by selective broadening/shifting of the smaller cis 
peaks in the tyrosyl region upon addition of CyPA. The 
broadening was not the result of increased viscosity with the 
addition of CyPA as the line-broadening effect reversed upon 
CsA addition (Fig. 3C). 
To quantitate the catalytic effect of CyPA, saturation trans-
fer experiments were conducted on the heptapeptide. The high 
field 5H prolyl cis resonance (3.37 ppm) was saturated as 
indicated by an 'X' in Fig. 4A which shows the enlargement 
of the proline 8H region of the heptapeptide substrate. Fig. 
4B-D show the NOE difference spectra of the heptapeptide, 
the heptapeptide with CyPA, and the heptapeptide with CyPA 
plus CsA, respectively. With saturation of the highest field cis 
resonance (X) in the heptapeptide alone, no saturation was 
transferred to its corresponding trans peak (X') (Fig. 4B). It 
should be noted that the B2 saturation pulse was not com-
pletely selective for the highest field cis resonance (3.37 ppm); 
a small amount of saturation at the adjacent low field cis 
resonance (3.50 ppm, labeled Z) was observed. This lack of 
absolute specificity, however, does not compromise the con-
clusions drawn from further analysis. In contrast to the free 
substrate (Fig. 4B), saturation transfer was observed from the 
highest field cis resonance at 3.37 ppm (X) to the lowest field 
trans resonance at 3.74 ppm (X') of the substrate in the pres-
ence of CyPA (Fig. 4C). Again, the less than perfect selectivity 
of the B2 saturation field is seen in that the partial saturation 
of the cis resonance at 3.50 ppm (Z) which, now in the pres-
ence of CyPA, is transferred to its corresponding trans reso-
nance at 3.58 ppm (Z'). Addition of a molar equivalent of 
CsA blocked the transfer of saturation observed for the sub-
strate in the presence of CyPA, a result consistent with CsA 
inhibition of CyPA catalysis. 
Quantitative measurement of the trans-cis isomerization 
rate was conducted utilizing saturation transfer methodology. 
The cis resonance at 3.37 ppm was irradiated for a variable 
time period and the intensity of the corresponding trans res-
onance at 3.74 ppm was observed (see methods for details). In 
the presence of CyPA, the interconversion rate for the Tyr-
Pro peptide bond in the model heptapeptide at 25°C was 
found to be 2.5 s_ 1 (Fig. 5). In the absence of CyPA, the 
trans-cis interconversion rate was too slow at 25°C for meas-
urement by this method. Therefore, saturation transfer experi-
ments were conducted at elevated temperatures (60-80°C) 
with the hope to extrapolate the uncatalyzed rate at 25°C 
from an Arrhenius plot. However, temperature dependent res-
onance shifts in the 5H Pro region of the spectrum resulted in 
the degeneracy of resonances compromising a quantitative 
analysis by saturation transfer. 
Enhancement of the trans-cis isomerization rate was also 
evidenced in NOESY spectra. Fig. 6 shows an enlargement 
ppm 
Fig. 3. Effect of CyPA and CsA on the tyrosyl spectral region of 
Ser-Gln-Asn-Tyr-Pro-Ile-Val at pH 6.8. (A) Heptapeptide substrate 
(1.6 mM peptide). (B) Substrate (1.6 mM) with CyPA (25 uM). (C) 
Substrate (1.6 mM), CyPA (25 uM), and CsA (25 uM). 
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Fig. 4. Observation of saturation transfer from cis resonance at 3.37 
ppm (X) to the trans resonance at 3.74 ppm (X'). (A) SH proline 
region. (B) NOE difference spectra of free substrate (1.6 mM pep-
tide). (C) NOE difference spectra of substrate (1.6 mM) with CyPA 
(25 uM). (D) NOE difference spectra of substrate (1.6 mM), CyPA 
(25 |xM), and CsA (25 uM). 
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Fig. 5. 1-D 'H-NMR saturation transfer experiment of the CyPA 
catalyzed Ser-Gln-Asn-Tyr-Pro-Ile-Val substrate at pH 6.8. The 
sample contains heptapeptide (2.0 mM), CypA (45 uM), and 50 
mM KPi. 
of the 1-3.0 ppm region of the spectrum for heptapeptide, 
heptapeptide:CyPA, and heptapeptide:CyPA:CsA. Compari-
son of the spectra of free heptapeptide (Fig. 6A) to the spectra 
of heptapeptide plus CyPA (Fig. 6B), reveals the appearance 
of exchange cross peaks (marked with arrows) between the 
YC^YT and |3C<->PT protons of the Pro residue. These cross 
peaks are eliminated upon addition of CsA (Fig. 6C). 
Our studies indicate that CyPA catalyzes the trans-cis iso-
merization about the Tyr-Pro peptide bond in a model sub-
strate, Ser-Gln-Asn-Tyr-Pro-Ile-Val, for a HIV-1 protease 
cleavage site in the gag polyprotein. These findings raise the 
interesting possibility that CyPA may be functioning in the 
HIV-1 virion to catalyze the generation of the conformers of 
gag and gag-pol precursor polyproteins necessary for cleavage 
by HIV protease. 
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Fig. 6. Effect of CyPA and CsA on Ser-Gln-Asn-Tyr-Pro-Ile-Val at pH 6.8 using 2-D NOESY experiments. (A) Heptapeptide substrate (1.6 
mM peptide). (B) Substrate (1.6 mM) with CyPA (25 uM). (C) Substrate (1.6 mM), CyPA (25 uM), and CsA (25 uM). Exchange cross peaks 
between the yc<-»Yr and PC<-»PT protons of the Pro residue are indicated by the arrows. 
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